| scholarly article | Q13442814 |
| P50 | author | Fraser D Russell | Q45015135 |
| P2093 | author name string | Peter Molenaar | |
| Joan Li | |||
| Jianchun Wang | |||
| P2860 | cites work | Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways | Q24649132 |
| Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure | Q28177421 | ||
| A calcineurin-dependent transcriptional pathway for cardiac hypertrophy | Q28269300 | ||
| The Myristoylated Alanine‐Rich C‐Kinase Substrate (MARCKS) is Sequentially Phosphorylated by Conventional, Novel and Atypical Isotypes of Protein Kinase C | Q28291411 | ||
| Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy | Q28343890 | ||
| Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure | Q28346745 | ||
| Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators | Q28566263 | ||
| Differential activation of transcription factors induced by Ca2+ response amplitude and duration | Q29619010 | ||
| The human heart endothelin system: ET-1 synthesis, storage, release and effect | Q34023346 | ||
| Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme | Q34246882 | ||
| Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial | Q34246891 | ||
| Cardiostimulant effects of urotensin-II in human heart in vitro | Q35043105 | ||
| AKAPs (A-kinase anchoring proteins) and molecules that compose their G-protein-coupled receptor signalling complexes | Q35625359 | ||
| Emerging roles of urotensin-II in cardiovascular disease. | Q35909083 | ||
| Determination of the specific substrate sequence motifs of protein kinase C isozymes | Q36842048 | ||
| Polar secretion of endothelin-1 by cultured endothelial cells | Q41129249 | ||
| Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase beta (HPTP beta) using synthetic phosphopeptides | Q41868748 | ||
| Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy | Q42169441 | ||
| Use of fluorinated tyrosine phosphates to probe the substrate specificity of the low molecular weight phosphatase activity of calcineurin. | Q43689393 | ||
| Angiotensin II induced cardiac hypertrophy in vivo is inhibited by cyclosporin A in adult rats | Q43840391 | ||
| Congestive heart failure and expression of myocardial urotensin II. | Q44036542 | ||
| Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy | Q44213168 | ||
| (-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the beta 1-adrenoceptor | Q44343048 | ||
| Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart | Q45015009 | ||
| Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure | Q47973168 | ||
| Phosphorylation of the calmodulin-dependent protein phosphatase by protein kinase C. | Q48319626 | ||
| Dose-Dependent Effects of the Renin Inhibitor Zankiren HCl After a Single Oral Dose in Mildly Sodium-Depleted Normotensive Subjects | Q56656065 | ||
| Calcineurin and human heart failure | Q56877814 | ||
| Inhibition of myocardial endothelin pathway improves long-term survival in heart failure | Q59063327 | ||
| Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes | Q60687218 | ||
| Revisiting calcineurin and human heart failure | Q62397376 | ||
| Plasma endothelin in chronic heart failure | Q68054244 | ||
| Inotropic effects of angiotensin II on human cardiac muscle in vitro | Q68606390 | ||
| Regulation of calcineurin by phosphorylation. Identification of the regulatory site phosphorylated by Ca2+/calmodulin-dependent protein kinase II and protein kinase C | Q69355977 | ||
| Dephosphorylation of protein kinase C substrates, neurogranin, neuromodulin, and MARCKS, by calcineurin and protein phosphatases 1 and 2A | Q72565963 | ||
| Both beta(2)- and beta(1)-adrenergic receptors mediate hastened relaxation and phosphorylation of phospholamban and troponin I in ventricular myocardium of Fallot infants, consistent with selective coupling of beta(2)-adrenergic receptors to G(s)-pr | Q73054101 | ||
| Molecular heterogeneity of protein kinase C expression in human ventricle | Q73131017 | ||
| Congestive heart failure: fifty years of progress | Q73194427 | ||
| Contractile and arrhythmic effects of endothelin receptor agonists in human heart in vitro: blockade with SB 209670 | Q73289600 | ||
| Calcineurin in human heart hypertrophy | Q74098248 | ||
| Activation of beta2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure | Q77781940 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 432-440 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensin II | |
| P478 | volume | 145 |
| Q61819782 | (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through β2-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling |
| Q26748814 | Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease |
| Q37394539 | Direct inotropic effects of exogenous and endogenous urotensin-II: divergent actions in failing and nonfailing human myocardium |
| Q36916953 | Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism. |
| Q62026465 | Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling |
Search more.